Global Rice Protein Based Infant Formula Market is expected to grow at a substantial CAGR of 5.9% in the forecast period of 2019 to 2026. The years considered for study are as mentioned below.
Global rice protein based infant formula market is an upcoming market which includes key players and local players. The market is growing owing to the favourable market scenario. The market has a prominent growth in upcoming years due to rising population of working mothers, growing infant population, increasing cases of breast cancer and rice based infant formula is widely accepted as non-allergic product.
The market has witness developments in terms of merger and acquisitions or product launches to enhance the product portfolio to meet the rising demand. For instance, in June 2018, Lactalis Group strengthened their position in the Middle East by signing a joint-venture with the Hanilor Company by covering both Smeds and Hanilor International subsidiaries. This strategy would help the company to strengthen its position in the Middle East by distributing their products.
Lactalis International dominated the rice protein based infant formula market. The other key players existing in the market includes are Novalac and Bayer AG, Nucitec SA de CV, La Mandorle, Laboratorios Ordesa, Kate Farms, BIOLAB PHARMA and others.
Lactalis International headquartered in Choisy-le-Roi, France and it was founded in 1999. The company is engaged in offering a broad range of dairy products for food service and retail networks. The company offers various brand products such as president, galbani, lactel, bridel, ambassador, santal, society, seriously, celia, picot, qbb, valbreso, pride and laicran. The product related to the global rice protein based infant formula market falls under the picot brand.
It has its global networks through direct sales representatives and distributors in the Asia, Middle East & North Africa, Africa, Dom-Tom and other countries. The company has various subsidiaries such as Lactalis Hong Kong Ltd (Hong Kong), Lactalis Dairy Products & Trading Middle-East (Dubai), Lactalis Japan (Japan), Lactalis Singapore Pte. Ltd (Singapore), Lactalis Indonesia (Indonesia) and others.
Novalac headquartered in Florence, Italy and it was founded in 1991. The company is engaged in offering various formulas that are developed for providing appropriate nutrients to the babies. The company mainly manages their operations through different product categories such 6/12 Months, 1/3 Years, and special milks. The product related to the global rice protein based infant formula market falls in the special milks category. It has its global networks through direct sales representatives and distributors in Europe, Latin America, Middle East, Africa and Asia-Pacific.
Bayer AG is headquartered in Leverkusen, Germany and founded in 1863. Bayer is a life science company mainly focusing and providing innovative products in the areas of agriculture and health care. The company operates through different business segments which include pharmaceuticals, consumer health, crop science and animal health. The product related to the global rice protein based infant formula market falls in the consumer health segment.
The company has wide geographical presence in North America, Latin America, Asia-Pacific, Europe, Middle East and Africa. It operates through its subsidiaries such as Monsanto Company (U.S.), Bayer HealthCare Pharmaceuticals LLC (Germany), Currenta (Germany), Jenapharm GmbH & Co. KG (Germany), and The Climate Corporation (U.S.) among others.
Global Rice Protein Based Infant Formula Market - Industry Trends and Forecast to 2026
Asia-Pacific Rice Protein Based Infant Formula Market - Industry Trends and Forecast to 2026
Europe Rice Protein Based Infant Formula Market - Industry Trends and Forecast to 2026
North America Rice Protein Based Infant Formula Market - Industry Trends and Forecast to 2026